DSIP: The Sleep Peptide Protocol — Science, Dosing & Research (2026)

What Is DSIP?

DSIP (Delta Sleep-Inducing Peptide) is a nine-amino acid neuropeptide that was first isolated from rabbit brain tissue in 1977. It was named for its ability to induce delta-wave sleep — the deepest, most restorative phase of sleep associated with growth hormone release, tissue repair, and memory consolidation.

Unlike pharmaceutical sleep aids (benzodiazepines, Z-drugs) that work by suppressing brain activity, DSIP appears to promote natural sleep architecture — supporting the transition into deep sleep without sedation, dependency, or next-day grogginess.

Mechanism of Action

• Delta wave induction: Promotes slow-wave (delta) sleep — the deepest sleep stage responsible for physical restoration and GH release
• Stress hormone modulation: Research suggests DSIP may reduce ACTH and cortisol levels, lowering the stress axis activity that prevents sleep onset
• LH modulation: Some studies show effects on luteinizing hormone release, suggesting broader neuroendocrine signaling
• Opioid system interaction: DSIP appears to interact with opioid receptors in a modulatory (not agonistic) capacity, which may contribute to its calming effects
• Antioxidant properties: Research has identified direct antioxidant activity, with DSIP reducing lipid peroxidation in animal models

Research Evidence

Insomnia & Sleep Quality

Human studies (primarily from European research groups) have shown that DSIP administration improves sleep onset latency, increases time spent in deep sleep stages, and reduces nighttime awakenings. Unlike benzodiazepines, it does not suppress REM sleep.

Chronic Pain & Sleep

DSIP has been studied for its analgesic properties in chronic pain patients where poor sleep and pain create a vicious cycle. Some studies suggest it reduces pain perception while simultaneously improving sleep quality.

Stress & Cortisol

Animal and limited human studies show DSIP reduces markers of stress response, including cortisol and ACTH. This may explain its effectiveness in stress-related insomnia where the HPA axis is overactivated.

Research Protocols

Stacking DSIP with Selank

The DSIP + Selank combination addresses both sides of the insomnia equation: Selank calms the anxious mind (GABA modulation, serotonin stabilization), while DSIP promotes the physiological transition into deep sleep. For people whose insomnia is driven by racing thoughts and stress, this stack tackles the root cause (anxiety) and the symptom (poor sleep) simultaneously.

• Selank: 250-500 mcg intranasal, 1-2 hours before bed
• DSIP: 100-200 mcg SC, 30-60 minutes before bed

Full Selank guide: Semax vs Selank Comparison

Where to Source DSIP

Side Effects & Safety

• Mild drowsiness (intended effect when taken before bed)
• Occasional headache upon waking (typically dose-related)
• No documented dependency or withdrawal in published research
• No REM suppression (unlike benzodiazepines)
• Limited long-term human safety data — cycles of 2-6 weeks are most commonly reported

Related Articles